肝癌患者肝动脉门静脉泵化疗给药方式改进实践  

Improvement of hepatic artery portal vein pump chemotherapy in patients with liver cancer

作　　者：王小瑜[1] 李绍惠 唐小丽[2] 顾琼[2] 陈晓琴[2] 

机构地区：[1]四川省肿瘤医院医学装备部,成都610041 [2]四川省肿瘤医院肝胆外科,成都610041

出　　处：《西南国防医药》2017年第9期956-958,共3页Medical Journal of National Defending Forces in Southwest China

摘　　要：目的探讨改进后的肝动脉、门静脉泵化疗给药方式在临床治疗中的应用效果。方法将2013年9月~2014年9月收治的80例肝癌患者设为对照组,2014年10月~2015年10月收治的89例肝癌患者设为试验组,对照组采用常规的肝动脉、门静脉泵化疗给药方式,试验组采用改良后的穿刺固定装置、泵药装置及给药方式。比较两组针头移位率、患者满意度、给药耗时及平均住院日。结果试验组针头移位率为0,患者满意度95.51%;对照组针头移位率为6.25%,患者满意度为82.50%;试验组平均住院时间,化疗药物泵入时间明显少于对照组(P<0.05)。结论改良的肝动脉、门静脉泵化疗给药方式,能有效降低针头移位率,提高患者满意度,缩短住院时间,提高床位周转率,提高护士工作效率。Objective To explore the application effects of improved hepatic artery portal vein pump chemotherapy in clinical treatment. MeAods 80 patients with liver cancer admitted from September 2013 to September 2014 constituted a control group and 89 patients with liver cancer admitted from October 2014 to October 2015 constituted an experimental group. Conventional hepatic artery portal vein pump chemotherapy was applied to the control group and improved hepatic artery portal vein pump chemotherapy to the experimental group. The needle shift rate, patient satisfaction, delivery time and average length of stay （LOS） between the two groups wee compared. Results The needle shift rate in the experimental group ＂was 0 and the patient satisfaction 95.51%; the needle shift rate in the control group was 6.25% and the patient satisfaction 82.50% ; the average LOS and the chemotherapy drug the pumping time in the experimental group were significantly shorter than those in the control group （P 〈 0.05）. Conclusion The improved hepatic artery portal vein pump chemotherapy can effectively lower the needle shift rate, improve patient satisfaction, shorten LOS and improve bed turnover rate and the work efficiency of nurses.

关 键 词：肝癌 泵化疗 给药方式 改进 

分 类 号：R735[医药卫生—肿瘤]